EUVIMEDEUVIMED entdecken
Crossref

CD3 + CD4 + T cells counts reflect the severity and prognosis of invasive pulmonary aspergillosis in patients with connective tissue disease-associated interstitial lung disease

Shenyun Shi, Ruyi Zou, Rui Li, Tingting Zhao, Chao Wu, Yonglong Xiao, Xuebing Feng, Lulu Chen

Clinical Rheumatology · 2025

DOI: 10.1007/s10067-025-07425-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, 2025. Verfasst von Shenyun Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, 210008, J…. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Invasive Pulmonary Aspergillosis, Connective Tissue Diseases, CD3 Complex. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: fundings for Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Invasive pulmonary aspergillosis (IPA) is a potentially fatal complication in patients with connective tissue disease-associated interstitial lung disease (CTD-ILD). The aim of this study is to investigate the clinical significance of CD3 + CD4 + T cells counts in CTD-ILD with IPA patients. METHODS: This retrospective study included 152 CTD-ILD patients admitted to a single center in China between January 2018 and June 2020. A total of 54 CTD-ILD patients with IPA were assigned to the CTD-ILD with IPA group, while 98 uninfected CTD-ILD patients were assigned to the control group. Serum CD3 + CD4 + T cells counts were compared between the above-mentioned two groups, and the correlations between CD3 + CD4 + T cells counts and the clinical features, mortality of CTD-ILD with IPA were also evaluated. RESULTS: CTD-ILD patients with IPA had significantly lower CD3 + CD4 + T cells counts than those with CTD-ILD without IPA (P < 0.001). The area under the receiver operating characteristic curve (AUROC) of discriminating CTD-ILD with IPA from CTD-ILD without IPA was 0.800 (95% CI, 0.722-0.878, P < 0.001). Correlation analyses showed that serum CD3 + CD4 + T cells counts were positively correlated with PaO2/FiO2 ratio(r = 0.317, P = 0.034) and negatively correlated with C reactive protein (CRP) (r = - 0.358, P = 0.009), erythrocyte sedimentation rate (ESR) (r = - 0.346, P = 0.014), and lactate dehydrogenase (LDH) (r = - 0.306, P = 0.026). In addition, 30 decedents with CTD-ILD infected IPA exhibited lower values of CD3 + CD4 + T cells compared with 24 survivors (P = 0.041). Furthermore, CD3 + CD4 + T cells counts were a prognostic factor and also associated with a higher mortality rate (log-rank test, P = 0.003). CONCLUSION: CD3 + CD4 + T cells counts could be a useful serum indicator associated with occurrence of IPA in CTD-ILD. Moreover, decreased CD3 + CD4 + T cells counts were associated with a poor survival of IPA in CTD-ILD patients. Key Points • CTD-ILD patients with IPA had significantly lower CD3+CD4+T cells counts than those with CTD-ILD without IPA. • Correlation analyses showed that serum CD3+CD4+T cells counts were positively correlated with PaO2/FiO2 ratio and negatively correlated with C reactive protein (CRP), erythrocyte sedimentation rate (ESR) and lactate dehydrogenase (LDH). • Decreased CD3+CD4+T cells counts were associated with a poor survival of IPA in CTD-ILD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialInvasive Pulmonary AspergillosisConnective Tissue DiseasesCD3 ComplexCD4-Positive T-LymphocytesHumansMaleFemaleMiddle AgedRetrospective StudiesPrognosisAdultAgedSeverity of Illness IndexLymphocyte CountChina

Stichwörter der Autor:innen

BiomarkerCD3 + CD4 + T cellsConnective tissue disease-associated interstitial lung diseaseInvasive pulmonary aspergillosisPrognosis

Substanzen

CD3 Complex

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China.
  • Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, Jiangsu, China.
  • Department of Infectious Diseases, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China.
  • Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China.
  • Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China. njchenlulu@sina.com.
  • Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, Jiangsu, China. njchenlulu@sina.com.

Förderung

  • fundings for Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University

Zitieren

APA

Shi, S., Zou, R., Li, R., Zhao, T., Wu, C., Xiao, Y., Feng, X., & Chen, L. (2025). CD3 + CD4 + T cells counts reflect the severity and prognosis of invasive pulmonary aspergillosis in patients with connective tissue disease-associated interstitial lung disease. Clinical Rheumatology. https://doi.org/10.1007/s10067-025-07425-9

Vancouver

Shi S, Zou R, Li R, Zhao T, Wu C, Xiao Y, et al. CD3 + CD4 + T cells counts reflect the severity and prognosis of invasive pulmonary aspergillosis in patients with connective tissue disease-associated interstitial lung disease. Clinical Rheumatology. 2025. doi:10.1007/s10067-025-07425-9

BibTeX
@article{Shi2025,
  author = {Shi, Shenyun and Zou, Ruyi and Li, Rui and Zhao, Tingting and Wu, Chao and Xiao, Yonglong and Feng, Xuebing and Chen, Lulu},
  title = {CD3 + CD4 + T cells counts reflect the severity and prognosis of invasive pulmonary aspergillosis in patients with connective tissue disease-associated interstitial lung disease},
  journal = {Clinical Rheumatology},
  year = {2025},
  doi = {10.1007/s10067-025-07425-9}
}
Kostenlos starten →